Forecasts data is unavailable for this security.
Consensus recommendation
- 18-May-23
- 15-Feb-24
- 14-Mar-24
- 18-Apr-24
- 16-May-24
Select bar for recommendation details.
Recommendations | 16-May-24 | |
---|---|---|
Buy | 2 | |
Outperform | 5 | |
Hold | 1 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast in AUD
The 7 analysts offering 12 month price targets for Telix Pharmaceuticals Ltd have a median target of 14.50, with a high estimate of 19.30 and a low estimate of 13.52. The median estimate represents a -2.03% decrease from the last price of 14.80.
High | 30.4% | 19.30 |
Med | -2.0% | 14.50 |
Low | -8.6% | 13.52 |
Earnings history & estimates in AUD
Average growth rate | -42.49% |
More ▼
Revenue history & estimates in AUD
Average growth rate | +579.21% |
More ▼